Talis Biomedical Corp Quarterly Return On Equity in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Talis Biomedical Corp quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2024.
  • Talis Biomedical Corp Return On Equity for the quarter ending June 30, 2024 was -79.7 %, a 12.8% decline year-over-year.
  • Talis Biomedical Corp annual Return On Equity for 2023 was -69.5 %, a 1.28% decline from 2022.
  • Talis Biomedical Corp annual Return On Equity for 2022 was -68.6 %, a 2.07% decline from 2021.
  • Talis Biomedical Corp annual Return On Equity for 2021 was -67.2 %, a 144% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -79.7 -9.02 -12.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -75.4 -6.32 -9.15% Jan 1, 2024 Mar 31, 2024
Q4 2023 -69.5 -0.88 -1.28% Oct 1, 2023 Dec 31, 2023
Q3 2023 -72.8 -12.9 -21.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -70.7 -12.4 -21.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -69.1 -2.53 -3.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -68.6 -1.39 -2.07% Oct 1, 2022 Dec 31, 2022
Q3 2022 -59.9 +43.9 +42.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -58.3 +109 +65.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -66.6 +333 +83.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -67.2 -219 -144% Oct 1, 2021 Dec 31, 2021
Q3 2021 -104 Jul 1, 2021 Sep 30, 2021
Q2 2021 -167 Apr 1, 2021 Jun 30, 2021
Q1 2021 -400 Jan 1, 2021 Mar 31, 2021
Q4 2020 152 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.